These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2156661)

  • 1. Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs.
    Kogire M; Izukura M; Gomez G; Uchida T; Greeley GH; Thompson JC
    Dig Dis Sci; 1990 Apr; 35(4):453-7. PubMed ID: 2156661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
    Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of beta-adrenergic agonists on gastric acid secretion in dogs.
    Stevens MH; Thirlby RC; Richardson CT; Fredrickson MA; Unger RH; Feldman M
    Am J Physiol; 1986 Oct; 251(4 Pt 1):G453-9. PubMed ID: 2876645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY inhibits gastric acid secretion stimulated by the autonomic nervous system.
    Clave P; Lluis F; Thompson JC; Greeley GH
    Biol Signals; 1992; 1(1):40-5. PubMed ID: 1364034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory action of peptide YY on gastric acid secretion.
    Guo YS; Fujimura M; Lluis F; Tsong Y; Greeley GH; Thompson JC
    Am J Physiol; 1987 Sep; 253(3 Pt 1):G298-302. PubMed ID: 2888314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat.
    Greeley GH; Guo YS; Gomez G; Lluis F; Singh P; Thompson JC
    Proc Soc Exp Biol Med; 1988 Dec; 189(3):325-8. PubMed ID: 2905061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gastric inhibitory polypeptide and intraduodenal or intravenous fat on gastric acid secretion from vagally innervated and denervated canine stomach.
    Konturek SJ; Konturek J; Cieszkowski M; Ebert R; Creutzfeldt W
    Dig Dis Sci; 1986 Jan; 31(1):49-56. PubMed ID: 3940823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY interacts with secretin and duodenal acidification to inhibit gastric acid secretion.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Townsend CM; Thompson JC
    Regul Pept; 1987 Aug; 18(3-4):155-63. PubMed ID: 3671783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
    Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
    Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of gastric inhibitory polypeptide to inhibit pentagastrin-stimulated acid secretion in vagotomized human subjects.
    Simmons TC; Taylor IL; Maxwell V; Brown JC; Grossman MI
    Dig Dis Sci; 1981 Oct; 26(10):902-4. PubMed ID: 6793335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal and peripheral modulation of gastric acid secretion and arterial pressure by neuropeptide Y, peptide YY, and pancreatic polypeptide in rats.
    Wager-Pagé SA; Rosenbaum G; Veale WL; Davison JS
    Peptides; 1993; 14(6):1299-308. PubMed ID: 8134313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide.
    Guo YS; Singh P; Draviam E; Greeley GH; Thompson JC
    Gastroenterology; 1989 Mar; 96(3):690-4. PubMed ID: 2644149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of physiological increases of plasma noradrenaline on gastric acid secretion and gastrointestinal hormones.
    Graffner H; Bloom SR; Farnebo LO; Järhult J
    Dig Dis Sci; 1987 Jul; 32(7):715-9. PubMed ID: 3595384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric acid secretion in streptozotocin-diabetic female rats.
    Lin CY; Yeh GH; Hsu FC; Tsai SC; Lau CP; Pu HF; Yu HL; Tung YF; Wang PS
    Chin J Physiol; 1991; 34(2):179-86. PubMed ID: 1835692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bethanechol prevents inhibition of gastric acid secretion by gastric inhibitory polypeptide.
    Soon-Shiong P; Debas HT; Brown JC
    Am J Physiol; 1984 Aug; 247(2 Pt 1):G171-5. PubMed ID: 6147097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements of peptide YY for biological activity at enteric sites.
    Yoshinaga K; Mochizuki T; Yanaihara N; Oshima K; Izukura M; Kogire M; Sumi S; Gomez G; Uchida T; Thompson JC
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G695-701. PubMed ID: 1443144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracolonic fat inhibits gastric acid secretion independent of gastrin release in the dog.
    Hashimoto T; Lluis F; Gomez G; Hill FL; Greeley GH; Thompson JC
    Dig Dis Sci; 1991 Jul; 36(7):888-92. PubMed ID: 2070700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human gastric acid secretion by peptide YY and secretin.
    Olsen O; Christiansen J
    Digestion; 1990; 47(3):156-9. PubMed ID: 2083801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man.
    Maxwell V; Shulkes A; Brown JC; Solomon TE; Walsh JH; Grossman MI
    Dig Dis Sci; 1980 Feb; 25(2):113-6. PubMed ID: 7353457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of terbutaline, a beta 2-adrenoreceptor agonist, on gastric acid secretion and serum gastrin concentrations in humans.
    Thirlby RC; Richardson CT; Chew P; Feldman M
    Gastroenterology; 1988 Oct; 95(4):913-9. PubMed ID: 3410234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.